Piper Sandler upgraded Solventum (SOLV) to Overweight from Neutral with a price target of $87, up from $78. The firm says the company posted another quarter of better sales performance and gave clarity on its tariff risk. As such, Solventum is now a “stock worthy of attention from value/GARP investors” as its sales growth is likely on a “slow climb” higher, its margins have a path “paved for consistent improvement” given a host of internal actions, and its capital allocation flexibility will increase meaningfully following unit sale, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOLV:
- Promising Growth and Strategic Flexibility: A Buy Recommendation for Solventum Corporation
- Trian Fund boosts Allstate, cuts Wendy’s in Q1
- Solventum Corp’s Earnings Call: Growth Amid Tariff Challenges
- Early notable gainers among liquid option names on May 9th
- Solventum Corporation: Hold Rating Amid Strong Results and Margin Challenges